Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2003
04/15/2003US6546783 Gas sensor and manufacturing method for the same
04/15/2003US6546782 High temperature pressurized high frequency testing rig and test method
04/15/2003CA2396662A1 Polymer sequence representation
04/15/2003CA2117378C Htlv-i/htlv-ii assay and method
04/15/2003CA2034504C Fungal stress proteins
04/12/2003CA2407214A1 Method of monitoring neuroprotective treatment
04/12/2003CA2403827A1 Compositions and methods for genetic analysis of polycystic kidney disease
04/10/2003WO2003029924A2 Adaptive baseline algorithm for quantitative pcr
04/10/2003WO2003029829A1 Lipoprotein fingerprinting method
04/10/2003WO2003029828A2 Screening method for different indications using bnpi and/or dnpi
04/10/2003WO2003029827A2 A method of detecting intracellular protein-protein interactions using three heterologous conjugates
04/10/2003WO2003029826A1 Method for detecting a cancer or precancerous condition
04/10/2003WO2003029825A2 Method for predicting the sensitivity to chemotherapy
04/10/2003WO2003029824A1 Method and agent for diagnosing and treating chronic inflammatory bowel diseases
04/10/2003WO2003029822A1 Specific binding analyzer and method of analyzing specific binding
04/10/2003WO2003029821A1 Target assisted iterative screening (tais) : a novel screening format for large molecular repertoires
04/10/2003WO2003029818A2 Methods and animal models for tumor formation involving dutti
04/10/2003WO2003029816A2 Method for finding novel active ingredients having androgen-type properties
04/10/2003WO2003029815A1 Device and method for the generation of arrays of substance mixtures by diffusion
04/10/2003WO2003029814A2 Neuropilin/vegf c/vegfr 3 materials and methods
04/10/2003WO2003029813A2 Test strips for the detection of prion proteins
04/10/2003WO2003029812A1 Methods for characterising gas-tight cement slur ries
04/10/2003WO2003029807A2 Ram-air sample collection device for a chemical warfare agent sensor
04/10/2003WO2003029804A1 Measurement instrument and concentration measurement apparatus
04/10/2003WO2003029802A1 Oil deterioration sensor
04/10/2003WO2003029801A1 Sulfur component sensor and sulfur component detector
04/10/2003WO2003029800A2 Membrane-covered sensor for determining the concentration of oxygen and carbon dioxide
04/10/2003WO2003029796A1 Method to improve sensitivity of molecular binding assays using phase-sensitive luminescence detection
04/10/2003WO2003029782A1 Nondestructive method and device for investigating underground air, nondestructive method for controlling contamination of soil, and pressure partition used for the control
04/10/2003WO2003029767A1 Electronic pulse detection apparatus and electronic pulse detection chip
04/10/2003WO2003029490A1 Methods and arrays for detecting biological molecules
04/10/2003WO2003029489A1 Methods for detection of target molecules and molecular interactions
04/10/2003WO2003029488A2 A method for the early detection of cancer
04/10/2003WO2003029484A2 Antimicrobial methods and materials
04/10/2003WO2003029482A2 Diagnosing, treating, and preventing cancer using cables
04/10/2003WO2003029480A2 Measurements of multiple molecules using a cryoarray
04/10/2003WO2003029479A2 Sensitive and rapid detection of pathogenic organisms and toxins using fluorescent polymeric lipids
04/10/2003WO2003029463A2 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
04/10/2003WO2003029462A1 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
04/10/2003WO2003029460A1 Polynucleotide fragments of an infectious human endogenous retrovirus
04/10/2003WO2003029451A2 Histone deacetylase 9
04/10/2003WO2003029450A1 Nucleic acid sequences encoding lysk from different borrelia strains and uses thereof
04/10/2003WO2003029437A2 Secreted proteins
04/10/2003WO2003029436A2 Ul16 binding protein 4
04/10/2003WO2003029431A2 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
04/10/2003WO2003029428A2 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease
04/10/2003WO2003029426A2 Human and murine cytokine polypeptides
04/10/2003WO2003029425A2 Whole cell engineering using real-time metabolic flux analysis
04/10/2003WO2003029424A2 Novel proteins and nucleic acids encoding same
04/10/2003WO2003029423A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
04/10/2003WO2003029422A2 Noonan syndrome gene
04/10/2003WO2003029418A2 Proliferation and differentiation of stem cells using extracellular matrix and other molecules
04/10/2003WO2003029415A2 Methods for determining oligosaccharide binding
04/10/2003WO2003029413A2 A novel g protein-coupled receptor, gave 10
04/10/2003WO2003029410A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER
04/10/2003WO2003029409A2 Methods for generating, selecting, and identifying compounds which bind a target molecule
04/10/2003WO2003029407A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof
04/10/2003WO2003029402A2 Unique properties of stem cells
04/10/2003WO2003029292A2 Gene regulatory peptides
04/10/2003WO2003029286A1 Fluorescent proteins
04/10/2003WO2003029285A2 Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections
04/10/2003WO2003029282A2 Tumor-peptide antigens from the human prdi-bf1-protein
04/10/2003WO2003029280A2 Grb7: novel regulator of lymphocyte signaling
04/10/2003WO2003029278A2 Il10-r: modulators of lymphocyte activation
04/10/2003WO2003029277A2 Modulators of lymphocyte activation and migration
04/10/2003WO2003029262A2 The human mob-5 (il-24) receptors and uses thereof
04/10/2003WO2003028889A1 Sample collector and test device
04/10/2003WO2003028737A1 Anti-viral agents and in-vitro method for the identification of candidates able to inhibit binding of polymerase to epsilon
04/10/2003WO2003028658A2 Oxidative stress in plasma
04/10/2003WO2003028647A2 Identification of genes involved in restenosis and in atherosclerosis
04/10/2003WO2003028631A2 Drug targets for alzheimer's disease and other diseases associated with decreased neuronal metabolism
04/10/2003WO2003028627A2 Method for detecting procoagulant conditions
04/10/2003WO2003028543A2 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
04/10/2003WO2003028539A2 Materials and methods for the diagnosis of pediatric tumors
04/10/2003WO2003028537A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
04/10/2003WO2003028536A2 Methods for diagnosing and treating heart disease
04/10/2003WO2003028444A1 Nonhuman mammal model of autoimmune disease having ox40l gene transferred thereinto
04/10/2003WO2003028442A1 Method of screening remedy for glaucoma
04/10/2003WO2003017935A9 Human antibodies specific for interleukin 15 (il-15)
04/10/2003WO2003010285A3 Functional site profiles for proteins and methods of making and using the same
04/10/2003WO2003007971A9 Improved heteropolymer complexes and methods for their use
04/10/2003WO2003006503A9 Chimeric g protein coupled receptors
04/10/2003WO2003005812A3 Modulation of metabolism of steroids and xenobiotics
04/10/2003WO2003004693A3 Methods and compositions for modulating adenosine triphosphate (atp) in cells and preventing cell injury or death via post-translational modifications to atp synthase
04/10/2003WO2003002974A3 Ecl labels having improved non-specific binding properties, methods of using and kits containing the same
04/10/2003WO2002096552A3 Biochip and apparatus and methods for its manufacture and use
04/10/2003WO2002095659A3 A system and method for managing gene expression data
04/10/2003WO2002095402A3 Individualization of therapy with hyperlipidemia agents
04/10/2003WO2002095355A3 Electrochemical method for high-throughput screening of minute quantities of candidate compounds
04/10/2003WO2002090959A8 A method for measuring the total concentration of carbon monoxide and hydrocarbons in oxygen by means of ion mobility spectrometry
04/10/2003WO2002090573A3 Biochip arrangement
04/10/2003WO2002088752A3 Method for detecting activator or inhibitor compounds of receptors of the family of the insulin receptor using an isolated chimeric receptor
04/10/2003WO2002087502A3 Antibodies abolish prion propagation and promote clearance of infectivity
04/10/2003WO2002086513A3 Transcobalamin ii assay method
04/10/2003WO2002086458A3 Method for measuring the folding behavior or folding resistance of blanks
04/10/2003WO2002084250A3 Methods for mass spectrometry detection and quantification of specific target proteins in complex biological samples
04/10/2003WO2002081504A3 Multimerization of hiv-1 vif protein as a therapeutic target
04/10/2003WO2002073197A3 Individualization of therapy with antidepressants
04/10/2003WO2002068602A8 Methods for modulating g2a receptor activity
04/10/2003WO2002068450A3 Plasma phospholipid transfer protein (pltp) deficiency represents an anti-atherogenic state and pltp inhibitor has anti-atherosclerosis action
1 ... 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 ... 3937